Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, Netherlands ISSN center , ProQuest, TdNet, Wanfang Data
The journal is indexed with, or included in, the following:
Aims and Scope
Asia Pacific Journal of Clinical Trials: Nervous System Diseases (CTNSD) is an open access, peer-reviewed, online journal that encompasses clinical trials, research, therapeutics and education for all aspects of nervous system diseases. CTNSD encourages full and transparent reporting of all research. We publish articles on general trial methodology as well as protocols, commentaries and traditional results papers - regardless of outcome or significance of findings.
July-September 2019| Vol 4| Issue 3
Mindfulness-based cognitive therapy for University students with depression, anxiety, and stress symptoms: a randomized controlled trial
Background and objectives: Early detection and intervention of depression, anxiety and stress symptoms in college can reduce the incidence of future mental health problems, thereby achieving ...
Bacteriological profile of endotracheal tube aspirates in head injury patients admitted in Neurosurgical Intensive Care Unit: a cross-sectional study from a tertiary care hospital of Central Nepal
Background and objectives: Many head injury patients have reduced consciousness, are prone to aspiration of oral secretions and likely develop pneumonia. The organisms causing such infection ...
Effectiveness of inpatient alcohol detoxification and psychotherapeutic support program: a prospective self-controlled study at a tertiary hospital in Nepal
Background and objectives: Alcohol use disorder is prevalent or common and associated with a range of physical and mental sequelae. Treatment gap exists in low and middle income countries. Th...
View All Articles in the Current Issue
Treatment with a halved dose of antipsychotics in patients with schizophrenia who relapse while receiving high-dose antipsychotic therapy
This study proposed and discussed a new treatment for patients with schizophrenia who relapse while receiving high-dose antipsychotic therapy. There is no drug therapy available for such patients. H...